Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2014 Aug;63(8):2613-6.
doi: 10.2337/db14-0691.

Bilirubin: a potential biomarker and therapeutic target for diabetic nephropathy

Travis D Hull  1 , Anupam Agarwal  2
Affiliations
Comment

Bilirubin: a potential biomarker and therapeutic target for diabetic nephropathy

Travis D Hull et al. Diabetes. 2014 Aug.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic of bilirubin generation and conjugation in the liver. The physiological properties of bilirubin may explain its ability to protect against the progression of DN. These properties make bilirubin a potential clinical biomarker or therapeutic target for a variety of disease states. BVR, biliverdin reductase; CAD, coronary artery disease; CO, carbon monoxide; CVD, cardiovascular disease; Fe2+, ferrous iron; Fe3+, ferric iron; NOS, nitric oxide synthase; RBC, erythrocyte; TNFα, tumor necrosis factor-α.
See this image and copyright information in PMC

Comment on

References

    1. American Diabetes Association Executive summary: Standards of medical care in diabetes—2012. Diabetes Care 2012;35(Suppl. 1):S4–S10 - PMC - PubMed
    1. Riphagen IJ, Deetman PE, Bakker SJL, et al. Bilirubin and progression of nephropathy in type 2 diabetes: a post-hoc analysis of RENAAL with independent replication in IDNT. Diabetes 2014;63:2845–2853 - PubMed
    1. Tenhunen R, Marver HS, Schmid R. Microsomal heme oxygenase. Characterization of the enzyme. J Biol Chem 1969;244:6388–6394 - PubMed
    1. Vítek L, Jirsa M, Brodanová M, et al. Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis 2002;160:449–456 - PubMed
    1. Adin CA, Croker BP, Agarwal A. Protective effects of exogenous bilirubin on ischemia-reperfusion injury in the isolated, perfused rat kidney. Am J Physiol Renal Physiol 2005;288:F778–F784 - PubMed

Publication types